loader image

The only escape he should be experiencing

Evaluate effective testosterone suppression in your patients' GnRH therapy.

Measure

  • Many men experience testosterone breakthroughs while on androgen deprivation therapy (ADT)10-14
  • Testosterone breakthroughs produce PSA increases, mimicking progression to castrate-resistant prostate cancer (CRPC)10-14
  • Neglecting to assess testosterone will fail to identify levels above the desired target throughout the dosing period, including microsurges, and escapes15
  • Testosterone (T) levels should be measured regularly in men receiving ADT to ensure T suppression is being maintained to target5
  • Adding a testosterone test to regular prostate-specific antigen (PSA) assessment is simple to implement and can help address these concerns15

Measuring testosterone levels helps to assess if biochemical castration has been achieved and maintained.5

  • Many men experience testosterone breakthroughs while on androgen deprivation therapy (ADT)10-14
  • Testosterone breakthroughs produce PSA increases, mimicking progression to castrate-resistant prostate cancer (CRPC)10-14
  • Neglecting to assess testosterone will fail to identify levels above the desired target throughout the dosing period, including microsurges, and escapes15
  • Testosterone (T) levels should be measured regularly in men receiving ADT to ensure T suppression is being maintained to target5
  • Adding a testosterone test to regular prostate-specific antigen (PSA) assessment is simple to implement and can help address these concerns15

ACT

  • Trelstar lowered testosterone below castration levels*
  • Consistent testosterone and PSA suppression regardless of strength7
  • Fewer testosterone breakthroughs than Lupron® in a head-to-head study2

Prescribe Trelstar for reliable testosterone suppression.

  • Trelstar lowered testosterone below castration levels*
  • Consistent testosterone and PSA suppression regardless of strength7
  • Fewer testosterone breakthroughs than Lupron® in a head-to-head study2

IS YOUR PROSTATE CANCER PATIENT Agonist Deficient?

Study Design

The 3.75 mg data are based on a 9-month, multicenter, parallel-group, blindly randomized, controlled clinical trial comparing Trelstar® mg to leuprolide acetate in patients with advanced (stage C/D) prostate cancer (N=284). Mean testosterone levels were calculated for months 2 to 9.

Order Trelstar from CuraScriptSD®

Trelstar can be ordered directly from our national specialty distributor, CuraScriptSD®, which provides next business day delivery and other convenient benefits. Call CuraScriptSD® at 877.599.7748.

If you already have a Trelstar account with CuraScriptSD®, please click here or register at www.curascriptsd.com.

Order Trelstar from AndaMEDS®

Trelstar can be ordered directly from our national specialty distributor, AndaMEDS, which provides next business day delivery and other convenient benefits. Call AndaMEDS at 1.855.468.5649, ext.74453.

If you already have a Trelstar account with AndaMEDS®, please click here or register at www.andameds.com.

Thank you for visiting.

You are now leaving a Verity website. A link to a non-Verity website does not constitute an endorsement of the products or services offered by the non-Verity website, and Verity is not responsible for the content of any non-Verity website.

Healthcare Professionals

The information contained in this website is intended for US Healthcare professionals only.